Investor Relations

Overview

MyoKardia is a clinical stage biopharmaceutical company pioneering a precision medicine approach to discover, develop and commercialize targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.

Read More

Recent Press Releases

Upcoming Events

There are currently no events scheduled.